All of the following are recommendations for screening of lynch syndrome in women with endometrial cancer except
**Core Concept**
Lynch syndrome is a hereditary condition that increases the risk of various cancers, including endometrial cancer. Screening recommendations for Lynch syndrome in women with endometrial cancer aim to identify individuals with the syndrome to provide early detection and management of associated cancers.
**Why the Correct Answer is Right**
Lynch syndrome is characterized by mutations in DNA mismatch repair genes, such as MLH1, MSH2, MSH6, and PMS2. Women with endometrial cancer and a family history of Lynch syndrome or those with tumors showing microsatellite instability (MSI-H) or deficient mismatch repair (dMMR) are recommended for screening. The screening recommendations include:
* Family history assessment
* Tumor testing for MSI-H or dMMR
* Germline testing for mismatch repair gene mutations
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because family history assessment is a crucial component of screening for Lynch syndrome in women with endometrial cancer. A strong family history of Lynch syndrome-related cancers, such as colorectal, ovarian, or endometrial cancer, increases the likelihood of Lynch syndrome.
**Option B:** This option is incorrect because tumor testing for MSI-H or dMMR is a recommended screening approach for Lynch syndrome in women with endometrial cancer. MSI-H or dMMR tumors are indicative of Lynch syndrome.
**Option C:** This option is incorrect because germline testing for mismatch repair gene mutations is a recommended screening approach for Lynch syndrome in women with endometrial cancer. Germline testing can identify individuals with a known mutation, allowing for targeted screening and management.
**Clinical Pearl / High-Yield Fact**
Women with endometrial cancer and a family history of Lynch syndrome or those with MSI-H or dMMR tumors should undergo screening for Lynch syndrome. This includes family history assessment, tumor testing, and germline testing for mismatch repair gene mutations.
**Correct Answer:** D.
This option is incorrect because it is not a recommended screening approach for Lynch syndrome in women with endometrial cancer.